Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
T Jandlová
Observed names:
T Jandlova,
T. Jandlova,
T. Jandlová
Institution:
Czech Academy of Sciences, Institute of Molecular Genetics
Observed institutions:
Czech Academy of Sciences,
Czech Academy of Sciences, Institute of Molecular Genetics
OpenAlex ID:
A5113704331
Immunotheraphy of cancer using local administration of lymphoid cells transformed by IL-2 cDNA and constitutively producing IL-2
1990
·
J. Bubeník
, J. Šimová
, et al.
·
Immunology Letters
·
84
Local administration of cells containing an inserted IL-2 gene and producing IL-2 inhibits growth of human tumours in nu/nu mice
1988
·
J. Bubenik
, N.N. Voitenok
, et al.
·
Immunology Letters
·
78
Growth inhibition of a MC-induced mouse sarcoma by TCGF (IL 2)-containing preparations
1983
·
J. Bubeník
, P. Perlmann
, et al.
·
Cancer Immunology Immunotherapy
·
62
Interleukin 2 gene therapy of residual disease in mice carrying tumours induced by HPV 16.
1999
·
J Bubeník
, J Símová
, et al.
·
International Journal of Oncology
·
36
Defect in lectin-induced interleukin 2 production by peripheral blood lymphocytes of patients with invasive urinary bladder carcinoma
1988
·
J. Bubeník
, J. Kieler
, et al.
·
Immunology Letters
·
21
Prophylactic, therapeutic and anti-metastatic effects of BMDC and DC lines in mice carrying HPV 16-associated tumours
2003
·
L. Mendoza
, J. Bubeník
, et al.
·
International Journal of Oncology
·
17
Immunogenicity of Dendritic Cell-Based HPV16 E6/E7 Peptide Vaccines: CTL Activation and Protective Effects
2004
·
Marie Indrová
, M. Reiniš
, et al.
·
Folia Biologica
·
16
PDF
Peritumoral Administration of Antigen-Unstimulated Bone Marrow-Derived Dendritic Cells Inhibits Tumour Growth
2000
·
Luis Mendoza
, M. Indrová
, et al.
·
Folia Biologica
·
15
Monoclonal antibodies against human urinary bladder carcinomas: Selectivity and utilization for gamma scintigraphy
1985
·
J. Bubeník
, J. Kieler
, et al.
·
European Journal of Cancer and Clinical Oncology
·
13
Tumour-inhibitory and antimetastatic effects of IL-2 in mice carrying MHC class I- tumours of HPV16 origin
2002
·
M. Indrova
, J. Bubenik
, et al.
·
International Journal of Oncology
·
11
Irradiated IL-2 gene-modified plasmacytoma vaccines are more efficient than live vaccines.
1998
·
J Símová
, J Bubeník
, et al.
·
International Journal of Oncology
·
9
Gene therapy of cancer: use of IL-2 gene transfer and kinetics of local T and NK cell subsets.
1993
·
J Bubeník
, J Zeuthen
, et al.
·
PubMed
·
9
Adjuvant Cytokine Treatment of Minimal Residual Disease after Surgical Therapy in Mice Carrying HPV16-Associated Tumours: Cytolytic Activity of Spleen Cells from Tumour Regressors
2003
·
Marie Indrová
, R. Mikyšková
, et al.
·
Folia Biologica
·
8
PDF
The Role of NK1.1+ Cells in the Protection against MHC Class I+ HPV16-Associated Tumours
2004
·
Jana Šímová
, J. Bubeník
, et al.
·
Folia Biologica
·
7
PDF
Tumour-Inhibitory Effects of Dendritic Cells Administered at the Site of HPV 16-Induced Neoplasms
2002
·
Luis Mendoza
, J. Bubeník
, et al.
·
Folia Biologica
·
7
Age-related decrease in transplantability of human tumours in nu/nu mice.
1992
·
J Bubeník
, J Kieler
, et al.
·
PubMed
·
7
Immunotherapeutic Efficacy of Vaccines Generated by Fusion of Dendritic Cells and HPV16-Associated Tumour Cells
2005
·
Jana Šímová
, J. Bubeník
, et al.
·
Folia Biologica
·
6
PDF
MHC Class I+ and Class I- HPV16-Associated Tumours Expressing the E7 Oncoprotein Do Not Cross-react in Immunization/Challenge Experiments
2003
·
Jana Šímová
, R. Mikyšková
, et al.
·
Folia Biologica
·
4
PDF
Local IFN-gamma therapy of HPV16-associated tumours.
2003
·
R Mikysková
, J Bieblová
, et al.
·
PubMed
·
4
Chemoimmunotherapy of cancer: potentiated effectiveness of granulocyte-macrophage colony-stimulating factor and ifosfamide derivative CBM-4A
2001
·
M. Indrova
, J. Bubenik
, et al.
·
Oncology Reports
·
4
Interleukin 2 gene therapy of surgical minimal residual tumour disease: characterization of cytolytic effector cells from tumour progressors and regressors.
1999
·
R Hájková
, M Indrová
, et al.
·
PubMed
·
4
Granulocyte-macrophage colony-stimulating factor-producing tumour vaccines.
1999
·
P Rössner
, J Bubeník
, et al.
·
PubMed
·
4
Genetically modified tumour vaccines
1997
·
P Rossner
, J Bubenik
, et al.
·
International Journal of Oncology
·
4
Thy-1 epitopes are expressed on murine myeloid leukemia and reticulum sarcoma cells
1983
·
J. Bubeník
, D. Bubeníková
, et al.
·
Immunology Letters
·
4
Immunotherapy of HPV 16-Associated Tumours with Tumour Cell Line/Dendritic Cell Line (TC-1/DC2.4) Hybrid Vaccines
2003
·
Jana Šímová
, J. Bieblová
, et al.
·
Folia Biologica
·
3
PDF
Show more works
View as search
Works count:
51
Citation count:
464
H-index:
10
I10-index:
10
Year
Topic
Type
